Pociredir oral capsule(s)
6058-SCD-101
Phase 1 small_molecule completed
Quick answer
Pociredir oral capsule(s) for Sickle Cell Disease is a Phase 1 program (small_molecule) at Fulcrum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fulcrum Therapeutics
- Indication
- Sickle Cell Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed